Archive ready
株式会社ジーエヌアイグループ 2022年12月期 第3四半期決算訂正
https://ssl4.eir-parts.net/doc/2160/tdnet/2209413/00.pdfMay 4, 2026 at 12:00 PM JST•The archive page, viewer, and downloads use this saved version.
May 4, 2026 at 12:00 PM JST·ssl4.eir-parts.net
The evidence pack includes HTML, screenshots, summaries, and metadata. It can be downloaded on Pro.
Saved PDF
株式会社ジーエヌアイグループ 2022年12月期 第3四半期決算訂正
StartedMay 4, 2026 at 12:00 PM JST
File size1.71 MB
SHA-256fec0c79e61c613251b00736b2657cde0dec9e87eade55d9335a206042bd77ea8
About this pageAI generated
This document is a notification regarding corrections to the 'Q3 Consolidated Financial Summary for the Fiscal Year Ending December 2022' released by GNI Group Inc. on November 16, 2022. The corrections are noted on pages 7, 11, and 16, with the amended content highlighted in red. Additionally, the document includes information about the company's business operations, market environment, and future outlook. GNI Group Inc. is a global healthcare company engaged in drug discovery and pharmaceutical development, operating in the United States and China.